Tags: New | antibiotics | fda | skin | infection

FDA Approves New Antibiotic For Skin Infections

Image: FDA Approves New Antibiotic For Skin Infections
(Copyright DPC)

Tuesday, 20 Jun 2017 09:31 AM

The U.S. Food and Drug Administration on Monday approved a new treatment for patients with acute bacterial skin infections, made by privately held Melinta Therapeutics.

The drug, Baxdela, or delafloxacin, is designed to treat skin and skin structure infections caused by a range of bacteria, including methicillin-resistant staphylococcus aureus, or MRSA.

Baxdela belongs to a common class of broad-spectrum antibiotics known as fluoroquinolones, which are typically given by infusion. Baxdela can be given both by infusion and in oral form.

The drug was shown in clinical trials to be no less effective than a combination of vancomycin, the go-to drug for serious gram-positive infections, and aztreonam, a drug to treat gram-negative infections, both of which are available in generic form.

Melinta estimates that about 40 percent of the 3 million patients hospitalized for serious skin infections receive two drugs, typically vancomycin and a gram-negative drug, rather than waiting for a lab test to determine whether the bug is gram-positive or gram-negative.

Dr. Eugene Sun, Melinta's chief executive, said the company plans to price the drug "competitively with other agents in the same space."

"We are acutely aware of the stresses on the (healthcare) system," he said.

© 2017 Thomson/Reuters. All rights reserved.

 
1Like our page
2Share
Health-News
Federal officials approved a new treatment for patients with acute bacterial skin infections, made by privately held Melinta Therapeutics.
New, antibiotics, fda, skin, infection
196
2017-31-20
Tuesday, 20 Jun 2017 09:31 AM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved